1. Insert Cover Image using Slide Master View Do not distortCoronary Stents Market India October 2013

2. Executive Summary Market Coronary stents market in India is expected to grow at a CAGR of x1%% over 2011 - 2017e There are three types of coronary stents available in the market, bare metal stents (BMS), drugeluting stents (DES), and bioabsorbable stents Drivers:Drivers & ChallengesGovernment Involvement Competitive Landscape Buyer Details Challenges:Increasing lifestyle based diseases Improving health infrastructure Changing demographics Increased healthcare spending and insurance coverage Advancements in technology and medical procedures Problems associated with usage Constant need for innovation and new product development Regulatory Bodies Regulatory Policies Regulatory Processes Major Foreign CompaniesMajor Domestic CompaniesCompany 1Company 3Company 5Company 2Company 4Company 6Top Hospitals Buying Coronary Stents in India Hospital 1Hospital 3Hospital 5Hospital 2Hospital 4Hospital 6CORONARY STENTS MARKET IN INDIA 2013.PPT2 3. Economic Indicators Introduction Market Overview Drivers & Challenges Government Involvement Regulatory Bodies Regulatory Policies Regulatory ProcessesCompetitive Landscape Buyer Details Recent Developments Strategic Recommendations Appendix CORONARY STENTS MARKET IN INDIA 2013.PPT3 4. Economic Indicators (1/3) GDP at Factor Cost: Quarterly INR tn 14a1 b112c1a2 b2 c211d1b4 c4b3d213c3d4d310 Q2 2009-10Q12010-11Q4Q3 2012-132011-12Inflation Rate: Monthly % 1.0ac0.8 0.6bdeFeb 2013 - Mar 2013Mar 2013 - Apr 20130.4 0.2 0.0Nov 2012 - Dec 2012Dec 2012 - Jan 2013Jan 2013 - Feb 2013SANITARYWARE MARKET IN INDIA 2013.PPT4 5. Indian market for coronary stents is poised to grow in the coming years with emphasis on drug-eluting stents Coronary Stents Market Overview Indian market for coronary stents is expected to show steady growth in coming years, providing strong opportunities to present and potential players to earn high revenues and increase their profits There are three types of coronary stents available in the market, bare metal stent, drug-eluting stents and bioabsorbable stents Type Y stents experience the highest demand while Type Z stents are still at a nascent stageMarket Size and Growth (Value-Wise) Type 1INR bnType 2Type 3 h3010 0gx1% cdaba1%b1%a2%b2%c2% c3%d2% d3%201120122013e2014ec1%d1%f3%f2%2015eg1%Type 2h1%v300h2% h3%2016e2017eux2% t400pq100p1%q1%0p2%q2%20112012200g2% g3%Type 3600 500f f1%Type 10004020Market Size and Growth (Volume-Wise)CORONARY STENTS MARKET IN INDIA 2013.PPTr r1% r3%r2%2013es s1% s2% s3% 2014et1%t3%t2%2015eu1%v1%u2% u3%v2% v3%2016e2017e5 6. Prices vary not only across stent types but also depending on whether it is indigenously manufactured or is foreign made Coronary Stents Price TrendsType of stentBare MetalBare MetalDrug-ElutingDrug-ElutingBioabsorbableIndigenous /ForeignIndigenousPrice (INR)Remarks These are price at which distributors purchase from manufacturers When hospitals procure stents directly from manufacturers, they can get up to x% discountsForeign Price at which distributors supply the stents to hospitals Difficult for hospitals to procure directly from manufacturers as these stents are manufactured outside IndiaIndigenous Price at which distributors purchase from manufacturers Hospitals can get discounts on these price by purchasing directly from the manufacturerForeign Price to the end-user, that is, the patients Distributors can procure the lower priced, foreign made DES for as little as INR aForeign Was priced INR u when it was launched in Dec 2012 Presently, Abbott has monopoly on these stents but in future as more companies produce these stents, the price is expected to fallCORONARY STENTS MARKET IN INDIA 2013.PPT6 7. Drivers & Challenges SummaryDrivers Increasing lifestyle based diseasesChallengesImproving health infrastructureProblems associated with usageChanging demographicsConstant need for innovation and new product developmentIncreased healthcare spending and insurance coverage Advancements in technology and medical proceduresCORONARY STENTS MARKET IN INDIA 2013.PPT7 8. Regulation of medical devices such as stents are done through different divisions under the MoHFW Organizational Structure Level 1Level 2Level 3Level 4Level 5Level 6ALevel 7ALevel 6BLevel 7BLevel 7CCORONARY STENTS MARKET IN INDIA 2013.PPTLevel 7D8 9. Although there isnt any specific legislation governing the entire medical devices industry, certain devices are Regulatory Bodies (1/2)Regulatory Body A Regulatory Body A is the main body for the regulation of pharmaceuticals and medical devices in India Within Regulatory Body A, Entity B is responsible for the regulating pharmaceuticals and medical devices and is advised by Body C and Body D It is responsible for establishing the safety, efficacy, and quality standards for pharmaceuticals and medical devices A list of regulated pharmaceuticals and devices, Indian Pharmacopeia, is published and updated by Regulatory Body A It also appoints notified bodies for conducting conformity assessment procedures including tests for all drug and device applications to ensure that it complies with all standards set by the body Regulatory Body A is also divided into several zonal offices which conduct the pre-licensing and post-licensing inspections, post-market surveillance, and recalls whenever necessary Apart from the regulatory functions, Regulatory Body A also offers technical guidance and trains regulatory officials and analysts as well as monitors adverse events Regulatory Body A also works with the World Health Organization to promote Good Manufacturing Practice (GMP)CORONARY STENTS MARKET IN INDIA 2013.PPT9 10. Market for coronary stents in India is dominated by products from foreign companies Competition OverviewMarket Share Volume-Wise (2012) MNCs have a dominant share in the coronary stents market in India Products from MNCs are generally viewed as superior to those manufactured by domestic companiesCompany 1Company 5Company 2Company 6Company 3OthersCompany 4 As a result of this, there is a higher uptake of products from foreign companies while Indian manufacturers find it difficult to get buyers for their products Even Company Y which exited the stents business in mid 2011, commanded u% share of the market in 2012 through its products that were stored as inventory Company 1, company 2 and Company 3 together account for ~m% of the market in terms of volume and n% of the market in terms of value Company 1 is the clear leader in the market with a% share in volume terms, followed by Company 2a%h%g% f%CORONARY STENTS MARKET IN INDIA 2013.PPTb% d% c%10 11. Competitive Benchmarking Private Companies (1/4) Key Ratios of Major Private Companies Operational Basis (FY 2012) (1/3) Operating Margin%Net Margin100 50a20b2a3a4 b3b4-50 -100-a1-b1Company 1Company 2Company 3Company 4 Company 4 recorded operating margin of a4%, higher than that of Company 3, Company 2 and company 1 which recorded operating margin of a3%, a2% and a1% respectively Net margin was highest for Company 3 at b3%%, followed by Company 4 which recorded a net margin of b4% Company 1 which recorded a negative net margin of a1% had the lowest net margin amongst its peersCORONARY STENTS MARKET IN INDIA 2013.PPT11 12. Private: Foreign Company Company 1 (1/5) Company InformationOffices and Centres IndiaCorporate Address Tel No. Fax No. Website Year of IncorporationMumbaiProducts and ServicesHead OfficeProducts/ServicesKey People NameDesignationPerson 1DirectorPerson 2DirectorPerson 3DirectorCORONARY STENTS MARKET IN INDIA 2013.PPT12 13. Private: Foreign Company Company 1 (2/5) Shareholders of the Company as on 27/06/2013 NameNo. of Shares heldOwnership Structure Foreign Holdings100.00%CORONARY STENTS MARKET IN INDIA 2013.PPT13 14. Private: Foreign Company Company 1 (3/5) Financial Snapshot Total IncomeKey Ratios Net Profit / LossParticularsINR bn 30INR bn a2b2255c2020-515d110-15 c15 a12009d220102011b120080-10 -20 -25Financial Summaryy-o-y change (2011-10)2011201020092008Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed AssetsCost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) Company earned a net profit of INR XX mn in FY 20XX, as compared to net profit of INR Y mn in FY 20YYLiquidity Ratios It reported total Income of INR XX mn in FY 20XX, registering an increase of X per cent over FY 20YYLeverage Ratios It earned an operating margin of X.X per cent in FY 20XX an increase of X.X percentage points over FY 20YY The company reported debt to equity ratio of X.XX in FY 20XX, an increase of X.X per cent over FY 20YYCurrent Ratio Cash Ratio Debt to Equity Ratio Debt to Capital Ratio Interest Coverage RatioEfficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover ImprovedCORONARY STENTS MARKET IN INDIA 2013.PPTDecline14 15. Private: Foreign Company Company 1 (4/5) Business Highlights DescriptionNewsOverview Company 1 operates in the Segment 1, Segment 2, segment 3 and Segment 4 It was previously the domestic formulations business of Company Y and was renamed as Company 1 after it was acquired by Company Z in 20--Manufacturing Facility It has a formulation facility at City 1, State 1 where a Product A is manufactured However, coronary stents sold by the company in India are manufactured by various subsidiaries of the parent company, company ZCoronary Stents Products A number of models of coronary stents from the company are available in India Model 1 Carotid Stent System and Model 2 Coronary Stent marketed by the company are manufactured by Company A, City 2, Country 2 Model 3 Coronary Stent System and Model 4 series are manufactured by Company B, City 3, Country 3 Model 5 Stent System is manufactured by Company C in its manufacturing facility at City 4, Country 4 Everolimus Eluting Model 6, Model 7, Model 8, Model 9, Model 10 and Model 11 are manufactured by Company B Model 12 stent system are manufactured by Company D, Country 5CORONARY STENTS MARKET IN INDIA 2013.PPT15 16. Private: Foreign Company Company 1 SWOT Analysis (5/5)SWOTCORONARY STENTS MARKET IN INDIA 2013.PPT16 17. Buyer Snapshot: List of Top 10 Buyers of Coronary Stents Top 10 hospitals buying coronary stents in India Hospital NameHospital LogoHospital ChainOwnership TypeAngioplasty Procedures Per MonthHospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5 Hospital 6 Hospital 7 Hospital 8 Hospital 9 Hospital 10CORONARY STENTS MARKET IN INDIA 2013.PPT17 18. Public: Domestic Company Hospital 1 (1/3) Company InformationHead Office and Hospital Network IndiaCorporate AddressTel No. Fax No. Website Year of IncorporationProducts and Services CategoryHead Office Hospital NetworkProducts/ServicesKey People NameDesignationPerson 1President (Institute Body)Person 2DeanPerson 3DirectorPerson 4Medical SuperintendentCORONARY STENTS MARKET IN INDIA 2013.PPT18 19. Public: Domestic Company Hospital 1 (2/3) Business Highlights DescriptionNewsOverview Is a group of m hospitals across India Has p teaching departments and centers Has a total of x beds There are y doctors and z nursesFacilities Leader in Therapy 1 It has India's first and only Therapy A training centre It is a pioneer of Type A surgeries in India, particularly System 1 for Therapy 2, and System 2Future Plans Expansion plans of the hospital chain were recently approved by the Body 1CORONARY STENTS MARKET IN INDIA 2013.PPT19 20. Public: Domestic Company Hospital 1 (3/3) ParameterHospital IndicatorsTotal cardiac patients per month Angioplasties per month Stent providersPurchase decision factors Stents procurement Contact DetailsCentralized/ Hospital level HOD/ Technician/ ProcurementProcedure/ process involved in procurement Contact details purchase Stent TypesOverview of Stent Procurement ProcessCORONARY STENTS MARKET IN INDIA 2013.PPT20 21. Thank you for the attention Coronary Stents Market India report is part of Netscribes Healthcare Industry Series. For any queries or customized research requirements, contact us at: Phone: E-Mail:+91 22 4098 7600 info@netscribes.comFollow us on:About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The companys expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients profitability and growth objectives. Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. CORONARY STENTS MARKET IN INDIA 2013.PPT21